Henlius Seeks To Add RA Indication To Chinese Rituximab

HLX01 Biosimilar Was First Approved In China Under New Pathway

 
• By David Wallace
  
Rheumatoid arthritis
Henlius is seeking to add the rheumatoid arthritis indication to its rituximab biosimilar • Source: Shutterstock
Generics Bulletin Podcast

Stay ahead of every shift in generics and biosimilars.

Generics Bulletin brings you the latest updates that matter for the off-patent industry.

SpotifyApple PodcastsWebsite

More from Biosimilars

More from Products